Nanki T - Search Results

1

Fractalkine/CX3CL1 in rheumatoid arthritis.

Nanki T, Imai T, Kawai S. Nanki T, et al. Mod Rheumatol. 2017 May;27(3):392-397. doi: 10.1080/14397595.2016.1213481. Epub 2016 Aug 2. Mod Rheumatol. 2017. PMID: 27484962 Review.

2

Influence of the rheumatoid arthritis-associated shared epitope on T-cell receptor repertoire formation.

Kohsaka H, Nanki T, Ollier WE, Miyasaka N, Carson DA. Kohsaka H, et al. Among authors: nanki t. Proc Assoc Am Physicians. 1996 Jul;108(4):323-8. Proc Assoc Am Physicians. 1996. PMID: 8863346

3

Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis.

Nanki T, Nagasaka K, Hayashida K, Saita Y, Miyasaka N. Nanki T, et al. J Immunol. 2001 Nov 1;167(9):5381-5. doi: 10.4049/jimmunol.167.9.5381. J Immunol. 2001. PMID: 11673556

4

Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis.

Nanki T, Imai T, Nagasaka K, Urasaki Y, Nonomura Y, Taniguchi K, Hayashida K, Hasegawa J, Yoshie O, Miyasaka N. Nanki T, et al. Arthritis Rheum. 2002 Nov;46(11):2878-83. doi: 10.1002/art.10622. Arthritis Rheum. 2002. PMID: 12428227 Free article.

5

Inhibition of fractalkine ameliorates murine collagen-induced arthritis.

Nanki T, Urasaki Y, Imai T, Nishimura M, Muramoto K, Kubota T, Miyasaka N. Nanki T, et al. J Immunol. 2004 Dec 1;173(11):7010-6. doi: 10.4049/jimmunol.173.11.7010. J Immunol. 2004. PMID: 15557198

6

[Role of chemokines in the pathogenesis of rheumatoid arthritis].

Nanki T. Nanki T. Nihon Rinsho. 2005 Jan;63 Suppl 1:195-9. Nihon Rinsho. 2005. PMID: 15799345 Japanese. No abstract available.

7

[Fractalkine and inflammatory diseases].

Imai T, Nishimura M, Nanki T, Umehara H. Imai T, et al. Among authors: nanki t. Nihon Rinsho Meneki Gakkai Kaishi. 2005 Jun;28(3):131-9. doi: 10.2177/jsci.28.131. Nihon Rinsho Meneki Gakkai Kaishi. 2005. PMID: 15997176 Free article. Review. Japanese.

8

Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis.

Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S, Miyasaka N. Nanki T, et al. Arthritis Rheum. 2005 Oct;52(10):3004-14. doi: 10.1002/art.21301. Arthritis Rheum. 2005. PMID: 16200580 Free article.

9

Inhibition of CX3CL1 (fractalkine) improves experimental autoimmune myositis in SJL/J mice.

Suzuki F, Nanki T, Imai T, Kikuchi H, Hirohata S, Kohsaka H, Miyasaka N. Suzuki F, et al. Among authors: nanki t. J Immunol. 2005 Nov 15;175(10):6987-96. doi: 10.4049/jimmunol.175.10.6987. J Immunol. 2005. PMID: 16272359

10

[Molecular mechanisms of bone destruction in rheumatoid arthritis].

Nanki T. Nanki T. Clin Calcium. 2007 Apr;17(4):510-6. Clin Calcium. 2007. PMID: 17404479 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters